Cedar Mountain Advisors, LLC Ocugen, Inc. Transaction History

Cedar Mountain Advisors, LLC

  • $446 Million
  • Q4 2024

A detailed history of Cedar Mountain Advisors, LLC transactions in Ocugen, Inc. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 100 shares of OCGN stock, worth $68. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Previous 100 -0.0%
Holding current value
$68
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 23, 2021
SELL
$1.66 - $15.81 $1,494 - $14,229
-900 Reduced 90.0%
100 $1,000
Q4 2020

Jan 28, 2021
BUY
$0.28 - $2.6 $280 - $2,600
1,000 New
1,000 $2,000

Others Institutions Holding OCGN

# of Institutions
123
Shares Held
68.6M
Call Options Held
478K
Put Options Held
253K
View Full List

About Ocugen, Inc.

OCGN Quotes by TradingView
  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $147M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Cedar Mountain Advisors, LLC Portfolio

Follow Cedar Mountain Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Mountain Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Mountain Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email